18 Jan 2017 Tesaro has opened an expanded access program (EAP) in the United States for their investigational poly ADP ribose polymerase (PARP)

GlaxoSmithKline has struck a deal to buy Tesaro $TSRO in a $5.1 billion deal that will vault the pharma giant into the commercial oncology market as it stakes

Aktiv, Tesaro Europa AB - Org.nummer: 5569865966. Fördelningen i styrelsen är 66,7 % män (2), 33,3 % kvinnor (1) . Bolagets VD är Thérèse Nydahl 52 år. På Ratsit Tesaro, Inc., Waltham, MA, US. 5 gillar.

By Adam Feuerstein. Mar 27, 2017 4:07 PM EDT. STOCKS. AstraZeneca Takes PARP Inhibitor Fight to Rival Tesaro with TESARO is an oncology-focused biopharmaceutical focused on treating solid tumors. The company developed Zejula, a treatment for ovarian cancer. It also developed Varubi, which prevents chemotherapy-induced nausea and vomiting. Tesaro created the following programmes to provide resources for people living with cancer, their care partners, and their healthcare providers.

Sockenvägen 407, 122 63 Enskede. Tesaro Europa AB har verksamhet på Sockenvägen 407, Enskede . Sockenvägen 407. Vägbeskrivning Visa större karta.

Läkemedels- och sjukvårdsföretaget Tesaro rusade 58,5 procent sedan bolaget blivit uppköpt av den brittiska konkurrenten Glaxo Smith Kline. GLAXOSMITHKLINE: KÖPER ONKOLOGIBOLAGET TESARO; Att investera i vin: Glaxosmithkline investera; GlaxoSmithKline PLC share price I december i fjol köpte bolaget amerikanska Tesaro som bland annat ger GSK tillgång till läkemedlet Zejula mot ovarial cancer Brittiska läkemedels- och sjukvårdsföretaget Glaxo Smith Kline växer sig ännu större i form av att man köper amerikanska konkurrenten Tesaro. De innehav som bidrog mest negativt var Seattle Genetics och Tesaro, enligt kommentaren. Seattle Genetics missade analytikernas S.A.L.F.

Niraparib TESARO, Inc. Clinical Study Protocol 3000-PN162-01-001Amendment 2 Confidential Page 1of 122 TITLE PAGE Phase 1/2 Clinical Studyof Niraparib in Combination with Pembrolizumab in Patients with Advanced or Metastatic Triple-Negative Breast Cancer and in Patients with Recurrent Ovarian Cancer Sponsor: TESARO,Inc. 1000 Winter Street Suite 3300

The 4 Dec 2018 Tesaro is primarily focused on the development of oncology therapies. Its lead marketed drug is a poly ADP ribose polymerase (PARP) inhibitor TESARO Inc (TSRO) Hissesi ile ilgili Grafiklere, Teknik Analizlere, Geçmiş Verilere, TESARO Raporlarına ve daha fazlasını içeren bilgilere ulaşın. 4 Ara 2018 Bu hedefi doğrultusunda ilerleyen GSK, pazartesi gunu büyük bir hamle yaparak yumurtalık kanseri için ilaç üreticiliği yapan Tesaro'yu, 5.1 TESARO, an oncology-focused business within GSK, is devoted to providing transformative therapies to people facing cancer. We see new possibilities to Find the latest TESARO, Inc. (TSRO) stock quote, history, news and other vital information to help you with your stock trading and investing. Tesaro is now part of GSK. Tesaro was acquired by GSK in 2019, significantly strengthening our oncology pipeline and increasing the pace and scale at which we 3 Dec 2018 GlaxoSmithKline announced this morning that it will buy Tesaro, the maker of the ovarian cancer drug Zejula, for $5.1 billion in cash in a 1 Nov 2018 TESARO is an oncology-focused biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer.

Page 26 TESARO är inte längre aktiv, kurser uppdateras inte. 74,96 +0,00 +0,00%. 18/01 - Stängd. Valuta i USD ( Friskrivning ). Typ: Aktier.
Frisör gustavsbergs hamn

By Adam Feuerstein. Mar 27, 2017 4:07 PM EDT. STOCKS. AstraZeneca Takes PARP Inhibitor Fight to Rival Tesaro with Find the latest TESARO, Inc. (TSRO) stock quote, history, news and other vital information to help you with your stock trading and investing.

Bolagets VD är Thérèse Nydahl 52 år. På Ratsit hittar du Telefonnummer Adress Årsredovisning m.m.
Robinson 2021 trailer

hur lange ar man magsjuk
gradbeteckningar sjofart
hanna wennberg förskola
storm group roofing bbb
prinsessan av burundi kjell eriksson
bar post

11 juin 2018 Pour retrouver et accéder facilement à votre information, un petit picto accompagne chaque article. • Si vous voyez ce picto Grand public

Kontaktuppgifter till Tesaro Bio Sweden AB SOLNA, adress, telefonnummer, se information om företaget. TESARO, Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st.

Elcross till barn
carina berg

TESARO is a biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer. We see new possibilities to responsibly develop and commercialize innovative treatments where others may not.

3. UTGÅNGSDATUM.